Statement From CHPA On Today’s FDA Advisory Committee Meeting On Dextromethorphan
The Consumer Healthcare Products Association issued the following statement on the Drug Safety and Risk Management Advisory Committee's recommendation not to schedule over-the-counter (OTC) medicines containing dextromethorphan: "Today's FDA advisory committee decision not to recommend scheduling OTC cough medicines containing dextromethorphan as a controlled substance refle...
(more...)
(more...)